Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis

Osteoarthritis (OA) is a common disabling disease worldwide, with no effective and safe disease-modifying drugs (DMOAD) in the market. However, studies suggest that drugs, such as liraglutide, which possess strong potential in decreasing low-grade systemic inflammation may be effective in treating O...

Descripción completa

Detalles Bibliográficos
Autores principales: Meurot, C., Martin, C., Sudre, L., Breton, J., Bougault, C., Rattenbach, R., Bismuth, K., Jacques, C., Berenbaum, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799666/
https://www.ncbi.nlm.nih.gov/pubmed/35091584
http://dx.doi.org/10.1038/s41598-022-05323-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799666/
https://www.ncbi.nlm.nih.gov/pubmed/35091584
http://dx.doi.org/10.1038/s41598-022-05323-7

Ejemplares similares